Patients with known CAD | All patients N = 693 | Patients without MACE N = 648 | Patients with MACE N = 45 | *P-value |
---|---|---|---|---|
CSBF at rest (mL/min) | 86.7 ± 32.9 | 84.7 ± 30.9 | 114.7 ± 44.9 | < 0.001 |
CSBF during ATP infusion (mL/min) | 236.4 ± 87.4** | 235.8 ± 88.7** | 245.3 ± 66.5** | 0.47 |
ΔCSBF (mL/min) | 149.7 ± 72.7 | 151.1 ± 73.8 | 130.6 ± 50.9 | 0.068 |
Coronary flow reserve | 2.84 ± 0.91 | 2.89 ± 0.92 | 2.27 ± 0.60 | < 0.001 |
Patients with suspected CAD | All patients N = 519 | Patients without MACE N = 472 | Patients with MACE N = 47 | *P-value |
---|---|---|---|---|
CSBF at rest (mL/min) | 89.8 ± 37.8 | 86.6 ± 36.7 | 122.2 ± 33.3 | < 0.001 |
CSBF during ATP infusion (mL/min) | 242.4 ± 87.4** | 241.6 ± 90.3** | 250.2 ± 48.5** | 0.52 |
ΔCSBF (mL/min) | 152.6 ± 70.1 | 155.1 ± 72.1 | 127.9 ± 39.2 | 0.011 |
Coronary flow reserve | 2.85 ± 0.84 | 2.93 ± 0.84 | 2.10 ± 0.40 | < 0.001 |